Similar Articles
1361 Histopathology of type C liver disease for determining hepatocellular carcinoma risk factors
1362 Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis
1363 Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation
1364 Efficacy of capecitabine and oxaliplatin regimen for extrahepatic metastasis of hepatocellular carcinoma following local treatments
1365 Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinoma
1366 Comparative effectiveness of traditional chemoembolization with or without sorafenib for hepatocellular carcinoma
1367 Systematic review of surgical resection vs radiofrequency ablation for hepatocellular carcinoma
1368 Hugl-1 induces apoptosis in esophageal carcinoma cells both in vitro and in vivo
1369 Hepatocellular carcinoma and food contamination: Ochratoxin A as a great prompter
1370 Glycyrrhizic acid attenuates CCl4-induced hepatocyte apoptosis in rats via a p53-mediated pathway
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA